PolyPeptide Group AG (CH:PPGN)
:PPGN
Total Valuation
PolyPeptide Group AG has a market cap or net worth of CHF903.40M. The enterprise value is CHF1.04B.
Market CapCHF903.40M
Enterprise ValueCHF1.04B
Share Statistics
PolyPeptide Group AG has 33,125,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,125,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PolyPeptide Group AG’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 1.14%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)1.14%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee287.72K
Profits Per Employee-15.64K
Employee Count1,362
Asset Turnover0.47
Inventory Turnover2.13
Valuation Ratios
The current PE Ratio of PolyPeptide Group AG is ―. PolyPeptide Group AG’s PEG ratio is -5.12.
PE Ratio―
PS Ratio2.36
PB Ratio2.72
Price to Fair Value2.72
Price to FCF-30.38
Price to Operating Cash Flow12.78
PEG Ratio-5.12
Income Statement
In the last 12 months, PolyPeptide Group AG had revenue of 391.87M and earned -21.31M in profits. Earnings per share was -0.64.
Revenue391.87M
Gross Profit64.32M
Operating Income7.41M
Pretax Income-21.41M
Net Income-21.31M
EBITDA44.42M
Earnings Per Share (EPS)-0.64
Cash Flow
In the last 12 months, operating cash flow was 77.08M and capital expenditures -107.38M, giving a free cash flow of -30.30M billion.
Operating Cash Flow77.08M
Free Cash Flow-30.30M
Free Cash Flow per Share-0.91
Dividends & Yields
PolyPeptide Group AG pays an annual dividend of CHF0.3, resulting in a dividend yield of ―
Dividend Per ShareCHF0.3
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change59.94%
50-Day Moving Average26.50
200-Day Moving Average24.80
Relative Strength Index (RSI)56.88
Average Volume (3m)34.07K
Important Dates
PolyPeptide Group AG upcoming earnings date is Aug 13, 2026, TBA (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
PolyPeptide Group AG as a current ratio of 1.74, with Debt / Equity ratio of 38.33%
Current Ratio1.74
Quick Ratio0.91
Debt to Market Cap0.12
Net Debt to EBITDA1.26
Interest Coverage Ratio0.40
Taxes
In the past 12 months, PolyPeptide Group AG has paid -106.69K in taxes.
Income Tax-106.69K
Effective Tax Rate<0.01
Enterprise Valuation
PolyPeptide Group AG EV to EBITDA ratio is 22.08, with an EV/FCF ratio of -32.22.
EV to Sales2.50
EV to EBITDA22.08
EV to Free Cash Flow-32.22
EV to Operating Cash Flow12.57
Balance Sheet
PolyPeptide Group AG has CHF74.53M in cash and marketable securities with CHF130.46M in debt, giving a net cash position of -CHF55.93M billion.
Cash & Marketable SecuritiesCHF74.53M
Total DebtCHF130.46M
Net Cash-CHF55.93M
Net Cash Per Share-CHF1.69
Tangible Book Value Per ShareCHF9.89
Margins
Gross margin is 16.44%, with operating margin of 1.89%, and net profit margin of -5.44%.
Gross Margin16.44%
Operating Margin1.89%
Pretax Margin-5.46%
Net Profit Margin-5.44%
EBITDA Margin11.34%
EBIT Margin1.89%
Analyst Forecast
The average price target for PolyPeptide Group AG is CHF35.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF35.50
Price Target Upside32.71% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast12.03%
EPS Growth Forecast-19.29%